Clinical Trial Update: A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin and capecitabine for unresectable metastatic hepatocellular carcinoma was terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Liver Cancer, Hepatocellular Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-10